ABBV Insider Trading Activity

Transactions disclosed by company insiders to the SEC on Form 4, most recent first.

InsiderRoleDateSharesValue
Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER 2026-08-14 32,710 $2,584,744
Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER 2026-08-14 32,710 $8,177,500

How Institutional Funds Moved on ABBV

Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.

FundChangeQuarter
NORGES BANK NORGES BANK opened a new position worth $6,430,543,942. 2026-06-30
GQG Partners LLC GQG Partners LLC opened a new position worth $483,559,978. 2026-06-30
JPMORGAN CHASE & CO JPMORGAN CHASE & CO opened a new position worth $5,777,558. 2026-06-30
GLENVIEW CAPITAL MANAGEMENT, LLC GLENVIEW CAPITAL MANAGEMENT, LLC opened a new position worth $37,472,467. 2026-06-30
683 Capital Management, LLC 683 Capital Management, LLC opened a new position worth $61,651,800. 2026-06-30
Sixth Street Partners Management Company, L.P. Sixth Street Partners Management Company, L.P. opened a new position worth $3,235,535,863. 2026-06-30
Susquehanna Portfolio Strategies, LLC Susquehanna Portfolio Strategies, LLC opened a new position worth $83,763,658. 2026-06-30
Erste Asset Management GmbH Erste Asset Management GmbH increased this position by 268% ($13,928,884 -> $51,269,677). 2026-06-30

Which Funds Hold ABBV

Largest reported positions as of 2026-06-30.

FundValueShares
VANGUARD CAPITAL MANAGEMENT LLC $29,038,274,101 115,396,098
VANGUARD PORTFOLIO MANAGEMENT LLC $12,199,002,913 48,477,996
GEODE CAPITAL MANAGEMENT, LLC $10,348,337,446 41,208,853
Capital Research Global Investors $7,574,798,407 30,101,551
NORGES BANK $6,430,543,942 25,554,538
Capital World Investors $4,826,436,854 19,178,966
Capital International Investors $3,936,357,038 15,638,631
FMR LLC $3,669,614,638 14,582,795
Sixth Street Partners Management Company, L.P. $3,235,535,863 12,854,734
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $3,235,535,863 12,854,734

Data compiled from public SEC filings. This is informational reporting, not investment advice.

HUB Investment Partners, LLC: 13F Portfolio Moves Tracked Quarterly

Chart summarizing HUB Investment Partners, LLC's 13F portfolio changes for the quarter ending 2026-06-30, including new positions, increases, and reductions.

HUB Investment Partners, LLC’s portfolio moves, tracked quarter by quarter through its SEC Form 13F filings. Like other superinvestor portfolio updates followed on this site, this profile compiles what the fund reports each quarter to the SEC on its U.S. equity and fund holdings, giving a running picture of how the firm’s positioning shifts over … Read more

Julia Letlow Buys AbbVie (ABBV) Again, Filed 105 Days Late

Screenshot-style graphic representing a congressional stock trade disclosure for AbbVie (ABBV) by Julia Letlow

A new Periodic Transaction Report filed with the U.S. House of Representatives shows Rep. Julia Letlow purchased shares of AbbVie Inc. (ABBV) common stock on April 28, 2025. The transaction was made personally by the member of Congress, not through a spouse or dependent, and is valued in the disclosed range of $1,001 to $15,000. … Read more

OSSIAM: 13F Portfolio Moves Tracked Quarterly

Chart illustrating OSSIAM's quarterly 13F portfolio changes for the quarter ending 2026-03-31

This page follows OSSIAM’s institutional portfolio moves as disclosed in its SEC Form 13F filings, updated every quarter as new data becomes available. Rather than a one-time snapshot, it’s built to be a running record of what the fund has been buying, trimming, and starting fresh with over time — a reference point for anyone … Read more

Julia Letlow Sold AbbVie (ABBV) Stock, Filed 199 Days Late

A U.S. House STOCK Act Periodic Transaction Report showing a sale of AbbVie (ABBV) stock by Rep. Julia Letlow

A new Periodic Transaction Report shows Rep. Julia Letlow (R-La.) sold shares of AbbVie Inc. (ABBV) common stock on January 24, 2025. The transaction was disclosed in a filing with the U.S. House of Representatives and is valued in the $1,001 to $15,000 range, the smallest bracket used on STOCK Act disclosure forms. The sale … Read more

Julia Letlow Bought AbbVie (ABBV) Stock, Filed 292 Days Late

Document graphic representing a congressional STOCK Act stock trade disclosure filing

A new disclosure filed with the U.S. House of Representatives shows that Rep. Julia Letlow purchased shares of AbbVie Inc. (ABBV) common stock, according to a Periodic Transaction Report submitted under the STOCK Act. The transaction is logged in our system as a congress buy signal. The report lists the transaction date as October 23, … Read more

Defilade Capital Management, L.P.: 13F Portfolio Moves Tracked Quarterly

Table summarizing Defilade Capital Management L.P.'s 13F portfolio changes for the quarter ending 2026-03-31, including new positions, increases, reductions, and exits.

This page tracks Defilade Capital Management, L.P.’s institutional portfolio moves as disclosed in its SEC Form 13F filings, updated every quarter as new filings become available. Because 13F filings report only quarter-end snapshots rather than exact trade dates, all activity below is described as occurring during the quarter ending 2026-03-31, and future updates will build … Read more

Sofinnova Investments, Inc.: 13F Portfolio Moves, Tracked Quarterly

Chart-style profile tracking Sofinnova Investments, Inc.'s quarterly 13F portfolio moves, including new positions, increased stakes, and exited holdings.

This page follows Sofinnova Investments, Inc.’s institutional portfolio as disclosed in its quarterly Form 13F filings with the SEC. A Form 13F is a required filing for institutional investment managers overseeing more than $100 million in U.S. equities, and it offers a snapshot of long positions held at the end of each quarter — not … Read more